Transcriptomics,Genomics

Dataset Information

29

Epigenetic upregulation of B-cell inappropriate genes induces extinction of B-cell program in classical Hodgkin lymphoma


ABSTRACT: A unique feature of the tumour cells (Hodgkin/Reed-Sternberg (HRS)) of classical Hodgkin lymphoma (cHL) is the loss of their B-cell phenotype despite their B-cell origin. Several lines of evidence suggest that epigenomic events, especially promoter DNA-methylation, are involved in this silencing of many B-cell associated genes. Here we show that DNA-demethylation alone or in conjunction with histone-acetylation is not able to reconstitute the B-cell gene expression program in cultured HRS cells. Instead, combined DNA-demethylation and histone-acetylation of B cells induce a nearly complete extinction of their B-cell expression program and a tremendous up-regulation of numerous cHL characteristic genes including key players such as Id2 known to be involved in the suppression of the B-cell phenotype. Since the up-regulation of cHL characteristic genes and the extinction of the B-cell expression program occurred simultaneously, epigenetic changes may also be responsible for the malignant transformation of cHL. The epigenetic up-regulation of cHL characteristic genes thus play - in addition to promoter DNA-hypermethylation of B-cell associated genes – a pivotal role for the reprogramming of HRS cells and explain why DNA-demethylation alone is unable to reconstitute the B-cell expression program in HRS cells. Keywords: Epigenetic modification Overall design: 5-aza-dC treatment: The cHL derived cell lines L428, KMH2 and L1236 were treated with 5-aza-dC at a concentration of 5 µM for 5 days with drug and medium replacement after each 48 hours. Combined 5-aza-dC/TSA treatment: The Burkitt lymphoma derived cell lines (Daudi, Namalwa and Raji)were treated with 5-aza-dC at a concentration of 3 µM for 6 days. 5-aza-dC and medium was replaced at day 2 and 5. At the fifth day - in addition to 3 µM 5-aza-dC - cells were incubated for 24 hours with 625 nM TSA. The gene expression profiles of the untreated and treated cell lines were generated in duplicates.

REANALYSED by: GSE21254GSE21252

INSTRUMENT(S): [HG-U133A] Affymetrix Human Genome U133A Array

SUBMITTER: Anke Ehlers  

PROVIDER: GSE8388 | GEO | 2007-11-01

SECONDARY ACCESSION(S): PRJNA101427

REPOSITORIES: GEO

altmetric image

Publications

Histone acetylation and DNA demethylation of B cells result in a Hodgkin-like phenotype.

Ehlers A A   Oker E E   Bentink S S   Lenze D D   Stein H H   Hummel M M  

Leukemia 20080207 4


A unique feature of the tumor cells (Hodgkin/Reed-Sternberg (HRS)) of classical Hodgkin lymphoma (cHL) is the loss of their B-cell phenotype despite their B-cell origin. Several lines of evidence suggest that epigenomic events, especially promoter DNA methylation, are involved in this silencing of many B-cell-associated genes. Here, we show that DNA demethylation alone or in conjunction with histone acetylation is not able to reconstitute the B-cell-gene expression program in cultured HRS cells.  ...[more]

Similar Datasets

2012-08-19 | E-GEOD-26101 | ArrayExpress
2012-08-19 | GSE26101 | GEO
| GSE86068 | GEO
2012-09-17 | E-GEOD-40160 | ArrayExpress
2015-08-25 | E-GEOD-72295 | ArrayExpress
2010-10-07 | GSE18454 | GEO
2010-10-07 | E-GEOD-18454 | ArrayExpress
| GSE82214 | GEO
2007-05-10 | E-SMDB-4105 | ArrayExpress
| PRJNA95605 | ENA